Table 4.
Transcription products of P/V genes as a result of mRNA editing in ThkPV-1, ThkPV-2, ThkPV-3 as compared to those reported in MenPV and TioPV.
| Transcription products | No. (%) of clones |
||||
|---|---|---|---|---|---|
| ThkPV-1 | ThkPV-2 | ThkPV-3 | MenPV (3) | TioPV (8) | |
| Total | 40 | 28 | 32 | 35 | 60 |
| V proteina | 29/40 (72.5%) | 5/28 (18%) | 15/32 (46.9%) | 27/35 (77%) | 27/60 (45%) |
| P proteinb | 11/40 (27.5%) | 23/28 (82%) | 17/32 (53.1%) | 7/35 (20%) | 30/60 (50%) |
| W proteinc | 0/40 (0%) | 0/28 (0%) | 0/32 (0%) | 1/35 (3%) | 3/60 (5%) |
a
mRNAs of ThkPV-1, ThkPV-2 and ThkPV-3 possessed no G insertion at the editing site, except one clone from ThkPV-1 and two clones from ThkPV-3 with 3 G insertions.
b
mRNAs of ThkPV-1, ThkPV-2 and ThkPV-3 possessed 2 G insertions at the editing site, except one clone from ThkPV-1 with 5 G insertions.
c
mRNAs of ThkPV-1, ThkPV-2 and ThkPV-3 expected to possess single G insertion at the editing site.